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Aortic remodeling after endografting of
thoracoabdominal aortic dissection
Julio A. Rodriguez, MD, Dawn M. Olsen, PA, Leonardo Lucas, MD, Grayson Wheatley, MD,
Venkatesh Ramaiah, MD, and Edward B. Diethrich, MD, Phoenix, Ariz
Purpose: This study assessed the clinical outcome, morphologic changes, and behavior of acute and chronic type B aortic
dissections after endovascular repair and evaluated the extent of dissection and diameter changes in the true (TL), false
(FL), and whole lumen (WL) during follow-up.
Methods: From May 2000 to September 2006, preprocedural and follow-up computed tomography scans were evaluated
in 106 patients. Indices of the TL (TLi) and FL (FLi) were calculated at the proximal (p), middle (m), and distal (d) third
of the descending thoracic aorta by dividing the TL or FL diameter by the WL. Analyses were by paired t test and 2.
Results: Stent grafts were used to treat 106 patients (mean age, 55 years, 70% men) with acute 59 (55.7%) and chronic 47
(44.3%) lesions. The entry site was successfully covered in 100 patients. The incidences of paraplegia and paresis were
2.8% and 1.0%. Mortality was 7.5% (8 patients), including two intraoperative deaths of contained ruptures. Seven (6.6%)
early endoleaks occurred. At a mean follow-up of 15.6 months, TLi improved from 0.45 to 0.88 in the proximal third
(p/3), from 0.42 to 0.81 in the middle third (m/3), and from 0.44 to 0.74 in the distal third (d/3), demonstrating
expansion of the TL. Two patients had decrease in TL due to endoleak needing reintervention. The FLi decreased from
0.41 to 0.06 in p/3, from 0.44 to 0.10 in the m/3, and from 0.42 to 0.21 in the d/3, indicating FL shrinkage. Changes
in the TLi and FLi were statistically significant. The decrease in the WL after repair was statistically significant in the
proximal and middle aorta. Fourteen patients (13.2%) had increase in WL; seven required a second intervention. FL
thrombosis occurred in 69 (65.1%). During follow-up, 36 (36.9%) patients had no retrograde flow, with complete
shrinkage of the FL. The FL completely shrank in 28 patients (26.4%) despite retrograde flow. The FL increased in eight
patients (7.5%); five needed reintervention. Thrombosis of FL was statistically significant with acute dissections and when
dissection remained above the diaphragm (type IIIA; P  .001 and P  .0133).
Conclusion: Remodeling changes were seen when the entry tear was covered. The fate of the FL was determined by
persistent antegrade flow and the level of the retrograde flow. Endografting for thoracic type B dissection was successful
and promoted positive aortic remodeling changes. ( J Vasc Surg 2008;47:1188-94.)The optimal treatment of type B aortic dissections is
becoming controversial. Medical treatment is the first line
of management, and surgical repair is reserved for those
who have organ or extremity malperfusion, impending
rupture, blood pressure refractory to medication, and per-
sistent pain. Medical treatment is favored rather than open
repair in noncomplicated acute dissection because of asso-
ciated surgical morbidity and mortality.1-4 The effective-
ness of endovascular treatment has been demonstrated in
various aortic pathologies with encouraging results5-13 and
appears very attractive in treating type B aortic dissections
because of the procedure’s relative safety and avoidance of
thoracotomy and aortic cross-clamping.
In patients managed with medical therapy, the false
lumen is subject to aneurysmal dilatation in 20% to 40%,
occurring usually between 2 and 5 years after the acute
phase.14-20 Although aggressive treatment with stent graft
placement in the descending thoracic aorta to exclude
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1188antegrade flow to the false lumen and avoid dilatation or
rupture seems logical, the long-term durability of this ther-
apy requires confirmation. Desired results with this modal-
ity are exclusion of false lumen, expansion of the true
lumen, reduction in whole lumen in aneurysmal disease,
and remodeling of the aorta.
This retrospective study assessed the clinical outcome,
morphologic changes, and behavior of acute and chronic
type B aortic dissection after endovascular repair. The ex-
tent of the dissection and the diameter changes in the true,
false, and whole lumen were also evaluated.
MATERIALS AND METHODS
Confirmation of dissection was based on contrast-en-
hanced computed tomography (CT) with scanning from
the supra-aortic vessels to the common femoral arteries.
The CT examinations were routinely performed preopera-
tively and within the immediate postoperative period, and
at 3, 6, and 12months and yearly thereafter. With each CT,
the extension of the dissection and diameter changes in true
and false lumen were measured. The extent of thrombosis
of the false lumen and evidence of false lumen antegrade/
retrograde flow were assessed. Diameter changes were eval-
uated between the preoperative and postoperative CTs
measurements. Acute dissection was defined as 14 days
from the onset of symptoms and chronic dissection was
defined as 14 days from the onset of symptoms.
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the true lumen diameter by the whole lumen diameter. The
false lumen index (FLi) was calculated in the same manner.
The desirable TLi value approaches or equals 1 (suggesting
increase in true lumen to normal), whereas the sought-after
FLi value approaches or equals 0 (suggesting shrinkage in
false lumen). The presence of false lumen thrombus may
prevent complete expansion of the true lumen, thus the TLi
may not reach 1. Results for FLi were analyzed using the
paired t test. False lumen thrombosis and retrograde flow
were assessed with 2. Measurements of three selected
aortic segments were made below the left subclavian artery,
at the carina level, and at the celiac artery level. These
measurements were obtained at the same level in each CT
scan and were made parallel to the line of the intimal flap
using a combination of anatomic parameters and digital
software.
The definition of technical success was (1) coverage of
initial tear/flap in the proximal descending thoracic aorta,
completely eliminating the antegrade flow in the false lu-
men; and (2) no proximal endoleak. Retrograde flow from
distal thoracic aorta, abdominal aorta, or iliac arteries was
not considered a failure unless expansion of the false lumen
was noted.
All patients were treated with commercially available
stent grafts or under investigative protocols. All acute type
B dissections received treatment except those that had
responded to medical therapy, had thrombosis of the false
lumen, or had  50% collapse of the true lumen, or a
combination of these. All patients presenting with chronic
type B aortic dissection had treatment for aneurysmal le-
sions with a diameter 60 mm.
An average of three CT scans per patient were evalu-
ated. The mean CT scan follow-up was 15.6 months
(range, 1-46 months), and 25% of the entire group had at
least 3 CTs and more than 24 months follow-up.
RESULTS
Stent grafts were used to treat 106 patients (mean age,
55 years, 70% men) with acute (55.7%) and chronic
(44.3%) lesions; of these, 64 (60.4%) were classified as
asymptomatic and 42 (39.6%) as symptomatic. Symptom-
atic patients were defined as those with organ or limb
malperfusion, intractable pain, and hemodynamic instabil-
ity. All patients included in this study had significant co-
morbidities (Table I).
The indications for endovascular repair were acute
symptoms in 39 patients (36.7%) and chronic dilatation in
47 (44.3%). Treatment was offered to 20 acute asymptom-
atic patients (18.8%) because of significant collapse of the
true lumen in hopes of preventing future sequelae of aneu-
rysmal dilatation. Also treated were 39 symptomatic pa-
tients (36.7%) with acute emergent type B aortic dissection,
including 10 (9.4%) with rupture, 8 (7.5%) with malperfu-
sion (3 renal and 7 lower extremity ischemia; 2 patients
having compromise of both), and 21 (19.8%) with intrac-
table pain. The remaining three symptomatic patients had
chronic dissections with pain due to aneurysmal dilatation.Four Marfanoid patients were treated, and two required
later conversion to open repair.
Dissections extended to the thoracic aorta in 35 pa-
tients (33.0%), to the visceral arteries in 22 (20.7%), to the
abdominal aorta in 19 (17.9%), and into one or both iliac
arteries in 30 (28.3%). The left renal artery flow came from
the false lumen in 14 patients (13.2%). The primary intimal
tear was just distal to the left subclavian artery in 102
patients (96.2%), whereas in the remaining four (3.7%), the
entry tear was in the middle third of the descending aorta.
Deployment of the stent grafts was successful in all
patients. Treatment was with one stent graft in 57 patients
(54%) and with two stent grafts in 40 (37.7%). The remain-
ing nine patients received three or four grafts. Gore TAG
stent grafts (W.L. Gore & Associates, Flagstaff, Ariz) were
used in 84 patients (79.2%), Endofit stent grafts (Endomed
Inc, Phoenix, Ariz) were deployed in 16 (15.0%), and
Talent endoprostheses (Medtronic Vascular, Santa Rosa,
Calif) were placed in six (5.6%). The diameter of the stent
graft was calculated from the largest diameter of the prox-
imal landing zone and oversized by 10% to 20%.
The preoperative mean (range) sizes of the whole lu-
men proximally was 49 (29-95), middle aorta was 42
(13-62), and distally was 34 (14-51) mm. After repair, the
means (ranges) were 44 (26-82), 40 (13-64), and 33
(16-50)mm, respectively. The decrease in the proximal and
middle aorta whole lumen was statistically significant (P 
.0001 and P .0148). The whole lumen increased in 14 of
the 106 patients (13.2%), occurring in nine chronic and five
acute cases. Seven patients had a minimal increase in the
whole lumen, with no identifiable endoleaks, remaining
near the size at initial presentation and 5 cm. These were
managed conservatively. Six of the remaining patients had
endovascular repair, one had open repair, and one had late
open repair 5 years postoperatively after an initially success-
ful endovascular repair.
The preoperative mean (range) sizes of the true lumen
were 29 (10-48), 26 (2-55), and 21(5-47) mm, and post-
operatively were 35 (18-44), 32 (13-43), and 24 (10-50)
mm. The increase in the true lumen in all three regions was
Table I. Patient comorbidities
Comorbidities No. %
Hypertension 106 100
Coronary artery disease 38 36
Peripheral artery disease 40 38
Diabetes mellitus 8 7
COPD 48 45
Cerebrovascular disease 10 9
Renal insufficiencya 21 20
End-stage renal disease 2 2
Obesity 9 8
Tobacco useb 62 58
COPD, Chronic obstructive pulmonary disease.
aDefined as 1.5 mg/dL.
bAny use during lifetime.statistically significant after repair (P  .0001, P  .0001,
.0; and
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lumen size in five patients (4.7%) and a decrease in two
(1.9%). Of the latter, the dissections were chronic in one
patient and acute in the other, and both required endovas-
cular reintervention to repair the compromise of the true
lumen. The mean (range) sizes of preoperative false lumen
were 16 (0-63), 15 (0-49), and 12 (0-36) mm, and these
decreased postoperatively to 7 (0-46), 8 (0-47), and 9
(0-37) mm. The decrease in false lumen size in all three
regions was statistically significant (P  .0001, P  .0001,
P  .0019; Table II). There was an increased false lumen
size in 8 patients (7.5%), half of which were chronic cases.
Five required repair because of expansion—four endovas-
cular at 3, 3, 12, and 60months, respectively, and one open
repair at 72 months.
The overall average preoperative TLi was 0.45 (0.46 in
acute, 0.34 in chronic) in the proximal third of the thoracic
aorta, 0.42 (0.47 in acute, 0.32 in chronic) in the middle
third, and 0.42 (0.46 in acute, 0.30 in chronic) in the distal
third. Postoperatively, the overall average TLi increased to
Table II. Actual lumen measurements before and after rep
Before repair
Prox Mid Dis Prox
True lumen
Minimum 10 2 5 18
Maximum 48 55 47 44
Mean 29 26 21 35
False lumen
Minimum 0 0 0 0
Maximum 63 49 36 46
Mean 16 15 12 7
Whole lumen
Minimum 29 13 14 26
Maximum 95 62 51 82
Mean 49 42 34 44
Dis, Distal third; Mid, middle third; Prox, proximal third.
aSignificant P value.
Table III. Comparison of overall lumen indices preoperat
Thoracic level
True lumen indexa
Pre-opa Post-op
Overall
P/3 0.45 0.88
M/3 0.42 0.81
D/3 0.42 0.74
Dissection type
Acute
P/3 0.46 0.92
M/3 0.47 0.89
D/3 0.46 0.78
Chronic
P/3 0.34 0.80
M/3 0.32 0.66
D/3 0.30 0.67
aValues in acute, chronic, and overall group. Desirable true lumen index, 10.88 (0.92 in acute, 0.80 in chronic) in the proximal third,to 0.81 (0.89 in acute, 0.66 in chronic) in the middle third,
and to 0.74 (0.78 in acute, 0.67 in chronic) in the distal
third (Table III). The increase in TLi was statistically sig-
nificant at all three levels (P  .0001). After repair, the
increase in the proximal and middle TLi was significant in
acute cases (Table III).
The overall average preoperative FLi was 0.41 (0.41 in
acute, 0.47 in chronic) in the proximal third, 0.44 (0.43 in
acute, 0.47 in chronic) in the middle third, and 0.42 (0.49
in acute, 0.31 in chronic) in the distal third. The overall
average postoperative FLi decreased to 0.06 (0.06 in acute,
0.09 in chronic) in proximal third, 0.10 (0.06 in acute, 0.22 in
chronic) in middle third, and 0.21 (0.18 in acute, 0.28 in
chronic) in the distal third (Table III). The decrease in FLi
was statistically significant at all three levels (P .0001, P
.0001, and P  .0008); Table III).
Complete false lumen thrombosis of the descending
thoracic aorta without evidence of antegrade or retrograde
flow occurred in 69 (65.1%) patients (Table IV). According
to the DeBakey classification of IIIA (above the dia-
r repair P
Mid Dis Prox Mid Dis
.0001a .0001a .0006a
13 10
43 50
32 24
.0001a .0001a .0019a
0 0
47 37
8 9
.0001a .0148 .2890
13 16
64 50
4033
and postoperatively, and acute versus chronic dissection
P
False lumen indexa
PPre-op Post-op
0001 0.41 0.06 .0001
0001 0.44 0.10 .0001
0001 0.42 0.21 .0001
0001 0.41 0.06
0001 0.43 0.06 .0001
0.49 0.18
0.80 0.09
0.62 0.22
0.61 0.28
false lumen index, 0.air
Afteively
.
.
.
.
.phragm) and IIIB (below the diaphragm), there were 25
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chronic type IIIB cases (Table IV). False lumen thrombosis
occurred in 23 (92.0%) of acute type IIIA, 22 (64.7%) of
acute type IIIB, 9 of chronic type IIIA, and 15 of chronic
type IIIB cases (Figs 1 and 2).
Thrombosis of the false lumen was significant, or more
common, for acute (P  .0010) and type IIIA cases (P 
Fig 1. Complete false lumen thrombosis of thoracic aorta
(DeBakey IIIA).
Table IV. Comparison of dissection extension (DeBakey
DeBakey Extenta No (%)
Graft covera
Prox Mid
Acute
IIIA 25 (23.5) 4 6
IIIB 34 (32.0) 1 10
Total 59 (55.6)
Chronic
IIIA 14 (13.2) 0 3
IIIB 33 (31.1) 1 15
Total 47 (44.3)
Total overall 106 (100) 6 (5.6) 34 (32
Abd-Ao, Abdominal aorta; Dist, sistal third; Mid, middle third; Prox, proxim
aExtent IIIA, above diaphragm; extent IIIB, below diaphragm..0133). False lumen thrombosis of acute dissections oc-curred between 1 day and 13 months (median, 2 days).
False lumen thrombosis of chronic dissections occurred
between 1 day and 12 months (median, 5 days). In 28
patients (26.4%), thrombosis of the false lumen occurred
from the proximal to the middle third of thoracic aorta
without evidence of antegrade flow. Eight (7.5%) of those
had proximal thrombosis only, and an endoleak had devel-
Fig 2. Complete false lumen thrombosis of thoracic aorta
(DeBakey IIIB).
fication) with false lumen and retrograde flow outcome
o. (%) False lumen thrombosis, No. (%)
Dist Prox Mid Dist
15 0 2 23
23 3 9 22
11 0 4 9
17 5 13 15
66 (62.2) 8 (7.5) 28 (26.4) 69 (65.1)
ird.classi
ge, N
)
al thoped in one. No retrograde flow in the thoracic aorta was
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was statistically significant for acute (P  .0124) and type
IIIA (P  .0124; Table IV).
Seven patients (6.6%) had postoperative endoleaks, six
had proximal type I endoleaks, and one had a type III
endoleak. Five of these six type I endoleaks were identified
perioperatively, with an attempt to treat intraoperatively.
The sixth type I endoleak was caused by graft collapse at 72
hours. Of the six type I endoleaks, an additional endolumi-
nal graft was placed in two patients that successfully sealed
the endoleak. Attempted endoluminal treatment failed in
the four other patients, two of whom died of multisystem
organ failure and one of arrhythmia before reintervention,
and the other required open repair. Three of the type I
endoleaks occurred in patients with acute dissections, and
the remaining three in chronic cases. Late endoleak (30
days) occurred in three patients, of whom two were type I,
and one patient had both type I and type II endoleaks. All
were treated with stent grafts, and coil embolization of the
subclavian artery was added in the patient with type II
endoleak.
Cerebrovascular accident (CVA) occurred in five pa-
tients, (4.7%), including a patient who sustained intracra-
nial bleeding (Table V). Spinal cord ischemia occurred in
four patients (3.8%), of which one (1.0%) had paresis and
Table IV. Continued.
P
Retrograd
Prox Mid D
.001 2 0
.001 2 4
.001 1 1
.001 4 6
9 (8.4) 11 (10.3) 33 (
Table V. Extent of dissections and complications
DeBakey
classificationa No. (%)
Subclavian coverage,
No. (%)
Acute
IIIA 25 (23.5) 1
IIIB 34 (32.0) 3
Total 59 (55.6)
Chronic
IIIA 14 (13.2) 0
IIIB 33 (31.1) 8
Total 47 (44.3)
Total overall 106 (100) 12 (11.3)
CVA, cerebrovascular accident.
aDeBakey IIIA, above diaphragm; IIIB, below diaphragm.three (2.8%) had paraplegia. Two patients received spinaldrains, and one regained sensation, the other resolved the
deficit in one limb and improved in the other. The remain-
ing two patients were critically ill; one had intracranial
bleeding, the other had bowel ischemia, and neither re-
ceived a drain. Three of the four incidences of spinal cord
ischemia occurred after acute emergency cases. One of the
patients with paraplegia had a contained rupture and the
left subclavian artery was covered. The other patient
resented with visceral and lower extremity malperfusion. The
left subclavian artery was intentionally covered in 12 pa-
tients (11.3%) without revascularization. An additional six
patients had left carotid-subclavian bypass before endolu-
minal stent grafting (Table V).
Eight patients (7.5%) died. Five deaths occurred with
emergency cases, and included two (1.8%) intraoperative
deaths caused by contained ruptures that became free rup-
tures. Three deaths followed elective cases, consisting of
two fatal arrhythmias and one intracranial hemorrhage.
DISCUSSION
Conservative management in the form of analgesia and
aggressive blood pressure control is the mainstay of therapy
for acute type B aortic dissections, with intervention re-
served for complicated cases.21 This approach is based on
the observation that mortality rates 10% can be achieved
, No.(%)
Abd-Ao None P
0 20 .001
9 7 .001
0 7 .001
6 2 .001
) 15 (14.1) 36 (36.9)
CVA,
No. (%)
Paraplegia,
No. (%)
Endoleak,
No. (%)
Mortality,
No. (%)
1 1 1 0
2 2 4 1
0 0 1 0
2 1 1 7
5 (4.7) 4 (3.7) 7 (6.6) 8 (7.5)e flow
ist
3
12
4
14
31.1with pharmacotherapy alone, in contrast to the 50% to 60%
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type B aortic dissection.21 The prognosis, however, is poor
for chronic type B aortic dissection managed conserva-
tively. The false lumen is subject to aneurysmal develop-
ment in 20% to 40% of the chronic dissection cases during
the next 2 to 5 years after the acute phase.14-21
In response to the high morbidity and mortality asso-
ciated with surgical aortic repair, especially in the presence
of ischemia, endovascular management of acute and
chronic aortic dissection was pioneered in the past decade,
with reported survival rates as high as 100%.10,11,22 The
approach to endovascular repair of type B aortic dissection
involves placement of the stent graft across the primary
entry tear with the objective of depressurizing the false
lumen and inducing proximal false lumen thrombosis. The
false lumen flow often persists in the lower thoracic and
abdominal aorta due to re-entry tears or intimal fenestra-
tions and is retrograde in orientation. Arresting the ante-
grade flow is the primary function of the stent graft.
By covering the proximal tear in acute dissections, we
obtained significant shrinkage of the false lumen within an
average of 6 months; in chronic dissections, shrinkage
occurred at average of 12months. The delay in shrinkage in
the latter cases may be due to the stiffness of the septum
that separates both lumens. The reduction in the false
lumen and FLi was statistically significant after stent graft-
ing, suggesting shrinkage of the false lumen. In addition,
the whole lumen decreased as well, suggesting a reduction
in aneurysmal dilatation. We believe covering the proximal
tear is the most important aspect of successful stent graft
treatment of the type B dissection and that it is key to
resolving antegrade flow and establishing thrombosis of the
false lumen. In addition, acute dissection and a limited
extent of dissection (type IIIA), correlated with increased
likelihood false lumen thrombosis, whereas chronic dissec-
tions and type IIIB dissections correlated with persistent
retrograde flow (Table IV).
Schoder et al23 recently reported that 90% of patients
were treated successfully for acute type B aortic dissection
with thrombosis of the false lumen in the stented segment;
however, false lumen perfusion distal to the stent graft
resulted in a diameter increase in some patients. In contrast,
we found persistent false lumen flow in the distal thoracic
and abdominal aorta was not associated with an increase in
the diameter of the false lumen at 15.6 months.
As noted, false lumen thrombosis occurred significantly
more often with acute and type IIIA dissections; this, along
with the likelihood of no retrograde flow in the thoracic
aorta, is encouraging and may be an incentive to treat acute
type IIIA dissections. Perhaps a randomized study may be
necessary comparing endoluminal grafting and optimal
medical management vs medical management alone for this
group. We did not observe aorta diameter expansion in
segments distal to the stented region; however, longer
follow-up is also necessary to determine if the false lumen
diameter increases. Expansion of the aorta was seen in those
who developed type I endoleaks. We cannot speculate
whether the endoleak led to aneurysmal expansion or theexpansion led to endoleak. At 1year, Nienaber et al24
showed some type of stent-induced aortic false lumen
thrombosis in nearly all of the stent graft patients treated,
but these are unpublished data.
The incidence of spinal cord injury in our series com-
pared favorably with the current outcomes of open repair in
acute and chronic cases.14 The paraplegia rate of 2.8% for
treatment with dissections is, however, somewhat higher
than the overall paraplegia rate of 1.5% of our entire tho-
racic series.25 To prevent neurologic symptoms, we medi-
cally induce hypertension to maintain mean arterial pres-
sure 90 mm Hg or above the patient’s baseline systolic
pressure, only treating a systolic blood pressure 180 mm
Hg. If neurologic symptoms develop, hypertension is
maintained, steroids are given, and if the patient fails to
show improvement 1 to 2 hours, a spinal drain is placed.
Debate exists regarding the need for extensive coverage
of the descending thoracic aorta to gain immediate expan-
sion of the true lumen and to eliminate retrograde flow or
malperfusion, or both. In this series, in which endovascular
grafting was limited to coverage of the proximal entry tear,
the increase in true lumen and TLi was statistically signifi-
cant, particularly at the proximal and middle regions, and
supports this approach. Although the paraplegia rate is still
fairly low, the “extensive coverage” approach may increase
the incidence of spinal cord injury.
We prefer to use a single graft; however, if the entry tear
remains patent, the true lumen collapses, or a second entry
site is identified, it may be necessary to place additional
grafts. The placement of a bare metal stent in the distal
thoracic aorta is an option when significant collapse of the
true lumen persists despite coverage of the proximal tear
with an endograft. This technique can be performed during
the initial procedure or as a staged procedure as described
by Nienaber to enhance expansion of the true lumen.26
With this approach, intercostal artery perfusion is main-
tained, while expansion of true lumen is observed.
We also covered the left subclavian artery in 18 patients
(17.0%) to effectively close the proximal tear that commu-
nicated with the false lumen. Six patients received a left
carotid–subclavian bypass before endoluminal grafting.
Spinal cord injury occurred in one of these patients, possi-
bly because collateral flow was sacrificed; however, this is
difficult to assess, because the patient also had a ruptured
thoracic aorta and episodic hypotension.
Some investigators have focused endovascular manage-
ment on acute thoracic dissection because remodeling
changes seem more likely to occur in early stages of this
condition.24,27 Our results, however, demonstrate that
both acute and chronic dissection can be treated success-
fully with stent grafts. The indications to treat acute dissec-
tion (36.7%) were malperfusion, rupture, an emergency
scenario, or a severely collapsed true lumen, whereas
chronic dissections (30%) were treated to manage aneurys-
mal dilatation. When chronic dissections were effectively
treated, and hence, there was resolution of false lumen
antegrade flow, the true lumen of the thoracic aorta re-
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creased.
CONCLUSION
The endovascular approach is feasible for the manage-
ment of acute and chronic type B dissections. This ap-
proach permits gradual aortic remodeling, and in some
cases, results in complete resolution of the false lumen.
Endoluminal grafting has the potential to become an ad-
junctive therapy to antihypertensive agents in the manage-
ment of thoracic type B dissections.
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